Steris (NYSE:STE) beat The Street on both sales and profits in its fiscal third quarter and announced that CEO Walt Rosebrough will step down July 29, 2021. The Dublin, Ireland-based sterilization and surgical products company posted profits of $114.5 million or $1.33 per share, on sales of $808.9 million for the three months ended Dec. 31, […]
Cantel Medical Corp.
Medtechs can’t set digital strategies aside – DTW Podcast
Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck. In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices. Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical, […]
MedTech 100 roundup: Finally a dip as industry stays relatively strong
After three consecutive weeks of record-breaking numbers, medtech industry stocks finally fell backward over the past seven days. MassDevice‘s MedTech 100 index finished last week at 105.8 (Jan. 15), marking a -0.95% drop from the 106.81 points (the highest ever total for the index) registered at the end of the week prior (Jan. 8). Medtech’s […]
BREAKING: Steris to acquire Cantel Medical in $4.6B deal
Steris (NYSE:STE) announced today that it will acquire Cantel Medical (NYSE:CMD) for $4.6 billion — a major merger in the infection prevention space. The deal is expected to close by June 30, pending customary closing conditions, regulatory approvals and an OK by Cantel shareholders. News of the merger comes a month and a half after Steris closed […]
Cantel Medical skyrockets on Street-beating Q1
Cantel Medical (NYSE:CMD) shares skyrocketed today on first-quarter results that comprehensively topped the consensus forecast. Shares of CMD were up 13.6% at $69.99 per share in mid-morning trading today. The Little Falls, N.J.-based company posted profits of $24.5 million, or 57¢ per share, on sales of $297 million for the three months ended Oct. 31, 2020, […]
Cantel Medical names new chief technology officer
Cantel Medical (NYSE:CMD) announced today that it hired Michael Drexel as its senior VP and chief technology officer. Little Falls, N.J.-based Cantel’s new hire will report to the company’s CEO, George Fotiades, and will operate out of Plymouth, Minn., according to a news release. Drexel’s primary responsibilities in his roles include driving R&D, oversight and leadership […]
Cantel Medical dips despite Street-beating Q4
Cantel Medical (NYSE:CMD) shares took a hit today despite fourth-quarter results that topped the consensus forecast. The Little Falls, N.J.-based infection prevention products and services company posted losses of -$2.3 million, or -5¢ per share, on sales of $233.4 million for the three months ended July 31, 2020, for a bottom-line slide into the red on […]
Cantel Medical names new president
Cantel Medical (NYSE:CMD) today said it has appointed Peter Clifford as president and chief operating officer. Clifford previously served as executive VP of the company and will continue to report to CEO George Fotiades under his new role. “Over the past sixteen months, Peter has distinguished himself as executive VP and COO. He has demonstrated exceptional […]
MedTech 100 roundup: Stocks stand pat in June’s first week
While the markets experienced some growth over the past week, stocks in the medtech industry remained practically unchanged over seven days. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 87.15 points at the end of last week (June 5). That total represents just a -0.02-point decrease […]
Cantel Medical up on Street-beating Q3
Cantel Medical (NYSE:CMD) shares ticked up today on third-quarter financial results that came in ahead of the consensus forecast. The Little Falls, N.J.-based infection prevention products and services company posted profits of $15.8 million, or 37¢ per share, on sales of $236.9 million for the three months ended April 30, 2020, for a 93.1% bottom-line gain […]
Cantel Medical pulls in $28m
Cantel Medical (NYSE:CMD) announced today that it sold $28 million in aggregate principal amount of convertible senior notes. The 3.25% convertible senior notes due in 2025 are pursuant to the full exercise by the initial purchasers of their option to purchase additional notes. Cantel Medical has issued a total of $168 million in aggregate principal amount […]
